BON
Bon Natural LifeBON
BON
About: Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.
Employees: 97
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
0% more ownership
Funds ownership: 0% [Q3] → 0% (+0%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for BON.
Financial journalist opinion
Based on 7 articles about BON published over the past 30 days
Neutral
GlobeNewsWire
5 days ago
BON Announces Apple Polyphenol Commercial Order Signed
XI'AN, China, April 11, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China's premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. The partnership leverages BON's patented extraction technology to deliver science-backed formulations combining antioxidant-rich apple polyphenols with plant-based proteins, proven to support weight management and metabolic health.
Neutral
GlobeNewsWire
1 week ago
BON Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin Activation
XI'AN, China, April 08, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation addresses nutritional critical challenges through a patent-pending Glucoraphanin-Myrosinase co-delivery system that significantly enhances the bio-activity of glucoraph anin, a key bio-active compound in broccoli. Broccoli stands as a nutrient-rich super food containing glucoraphanin-the vegetable's key bio-active compound that could metabolically converted into sulforaphane within biological systems.
Neutral
GlobeNewsWire
1 week ago
Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age
New York, New York, April 07, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), New York's premier boutique investment bank, is proud to announce a strategic investment from Nestpoint Group (“Nestpoint”), a leading firm in government affairs, finance, and private equity based in Dallas and Washington, D.C. This powerhouse partnership positions Univest to rise as a global investment banking leader, harnessing unparalleled opportunities for economic expansion under the Trump administration's bold vision for American prosperity.
Neutral
GlobeNewsWire
1 week ago
BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments
XI'AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, our company achieved groundbreaking progress in the bio-manufacturing technology of tea pigments, attaining an industrial-leading yields rate of 12-16% while maintaining purity levels surpassing 95%. Demonstrating significant biological properties including lipid-lowering, blood glucose reduction, antioxidant effects, and anti-peptic ulcers, tea pigments exhibit broad applicability across multiple health sectors.
Neutral
GlobeNewsWire
3 weeks ago
BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch
XI'AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term.
Neutral
GlobeNewsWire
4 weeks ago
Univest Securities, LLC Announces Closing of $12 Million Best Efforts Offering for its Client Bon Natural Life Limited (NASDAQ: BON)
New York, New York, March 18, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of Best Efforts Offering (the “Offering”) for its client Bon Natural Life Limited (NASDAQ: BON) (the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries.
Positive
Benzinga
4 weeks ago
Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Neutral
GlobeNewsWire
1 month ago
Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering
XI'AN, China, March 17, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has priced a best efforts offering of units as described below for aggregate gross proceeds to the Company of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering of ordinary units (or pre-funded units in lieu of such ordinary units) comprised of 8,333,332 shares of the Company's Class A ordinary shares (or pre-funded warrants in lieu of Class A ordinary shares for the pre-funded units), Series A Warrants to purchase one Class A ordinary shares at an exercise price of $1.44 per share (the “Series A Warrants”) and Series B Warrants to purchase Class A ordinary shares at an exercise price of $2.16 per share (the “Series B Warrants” and, together with the Series A Warrants, the “Warrants”).
Neutral
GlobeNewsWire
11 months ago
Bon Natural Life Limited Announces Brand Strategic Cooperation with Guangdong JUWO
XI'AN, China, May 14, 2024 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that its operating subsidiary, Xi'an App-Chem Bio (Tech) Co., Ltd., reached a strategic cooperation agreement with Guangdong JUWO Trading Co., Ltd.
Neutral
GlobeNewsWire
1 year ago
Bon Natural Life Limited Announces Major Breakthrough in Apple Polyphenol Technology, Set to Boost Fiscal 2024 Sales
XI'AN, China, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solution providers in the natural, health and personal care industries, today announced that the Company has achieved significant breakthrough in apple polyphenol extraction technology. This development is set to drive considerable growth in BON's apple polyphenol products in the upcoming fiscal year.
Charts implemented using Lightweight Charts™